Clinical Trial Update: Safety of Nitroglycerin for Field Treatment of STEMI

View source ↗

Summary

A completed clinical trial update evaluating the safety of nitroglycerin for field treatment of ST-elevation myocardial infarction (STEMI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• NITROGLYCERIN (Nitroglycerin)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Myocardial Infarction | Status: COMPLETED